ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD

Zhejiang Huahai Pharmaceutical Co., Ltd. is primarily a **manufacturer**.

Company Introduction:

Zhejiang Huahai Pharmaceutical Co., Ltd. is a leading global pharmaceutical enterprise headquartered in China. It specializes in the research, development, manufacturing, and sales of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and finished dosage forms (FDFs). The company is recognized for its robust R&D capabilities, advanced production technologies, and adherence to international quality standards and regulatory requirements.

Although Zhejiang Huahai Pharmaceutical Co., Ltd. is a Chinese company, it maintains a substantial international presence and business activities globally, including in India. In the Indian context, the company operates primarily as a major supplier and manufacturer whose products, particularly APIs, are distributed and sold to the Indian pharmaceutical market through sales channels, distribution networks, and strategic collaborations. Therefore, within India, it functions as a key manufacturing entity providing essential pharmaceutical components to the local industry.

Zhejiang Huahai Pharmaceutical Co., Ltd. supplies a range of Active Pharmaceutical Ingredients (APIs) and some finished dosage forms to the Indian market. Their primary focus in India is on APIs.

Key products include:

Sartan-class APIs: Valsartan, Irbesartan, Candesartan Cilexetil, Losartan Potassium, Olmesartan Medoxomil.

Other APIs: Clopidogrel Bisulfate, Donepezil Hydrochloride, Aripiprazole, Quetiapine Fumarate, Risperidone, Montelukast Sodium, Rosuvastatin Calcium, Atorvastatin Calcium.

They also engage in contract manufacturing and supply of certain finished dosage forms, but their most prominent presence in India is through the supply of these active pharmaceutical ingredients to other pharmaceutical companies for formulation into medicines.